Transdermal siRNA delivery by pH-switchable micelles with targeting effect suppress skin melanoma progression

被引:73
作者
Wang, Mao-Ze [1 ]
Niu, Jie [1 ]
Ma, Hui-Jian [1 ]
Dad, Haseeb Anwar [1 ]
Shao, Hai-Tao [1 ]
Yuan, Tie-Jun [1 ]
Peng, Li-Hua [1 ,2 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, 866 Yuhangtang Rd, Hangzhou 310058, Peoples R China
[2] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
基金
中国国家自然科学基金;
关键词
CATIONIC LIPIDS; GENE DELIVERY; CANCER; PEPTIDE; CD44; NANOPARTICLES; TUMOR; PENETRATION; COPOLYMER; EPIDERMIS;
D O I
10.1016/j.jconrel.2020.03.023
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Melanoma is an aggressive disease with rapid progression and fast relapse, representing one of the formidable challenges in clinic. Current systemic therapies for melanoma exhibit limited anticancer potential due to the lack of specificity and limited efficacy. Herein, we design a cationic polymer (SCP-HA-PAE) by conjugating skin/cell penetrating peptide (SCP) and hyaluronic acid (HA) to the amphipathic polymer (poly β-amino esters, PAE), then fabricate the nanocarriers (SHP) composed by SCP-HA-PAE for delivering siRNA to skin melanoma by transdermal application. SHP not only manifests the excellent ability in penetrating through skin stratum corneum (SC), targeting melanoma and being sensitive to pH, but also expresses the advantages in compacting the vector/siRNAs nanocomplexes and stimulating their endosome escape inside cells, which ensure the enhanced siRNA delivery efficiency. SHP/siRNA induce the strong efficacy in retarding the progression and relapse of skin melanoma through the enhanced apoptosis effect both in vitro & in vivo. This study provides a proof-of-concept design of pH-switchable cationic micelles as transdermal gene delivery nanoplatforms with targeting effect for melanoma therapy, which may be adapted widely in the treatment of various superficial tumors and skin genetic diseases. © 2020
引用
收藏
页码:95 / 107
页数:13
相关论文
共 64 条
[1]   Skin models for the testing of transdermal drugs [J].
Abd, Eman ;
Yousef, Shereen A. ;
Pastore, Michael N. ;
Telaprolu, Krishna ;
Mohammed, Yousuf H. ;
Namjoshi, Sarika ;
Grice, Jeffrey E. ;
Roberts, Michael S. .
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2016, 8 :163-176
[2]   Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid [J].
Ahrens, T ;
Sleeman, JP ;
Schempp, CM ;
Howells, N ;
Hofmann, M ;
Ponta, H ;
Herrlich, P ;
Simon, JC .
ONCOGENE, 2001, 20 (26) :3399-3408
[3]   Approaches for breaking the barriers of drug permeation through transdermal drug delivery [J].
Alexander, Amit ;
Dwivedi, Shubhangi ;
Ajazuddin ;
Giri, Tapan K. ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Tripathi, Dulal Krishna .
JOURNAL OF CONTROLLED RELEASE, 2012, 164 (01) :26-40
[4]   Opinion - Survivin, cancer networks and pathway-directed drug discovery [J].
Altieri, Dario C. .
NATURE REVIEWS CANCER, 2008, 8 (01) :61-70
[5]  
[Anonymous], 2019, J NANOBIOTECHNOLOGY, DOI DOI 10.1186/1741-7015-11-1
[6]   CROSS-REACTIVITY BETWEEN THE EBNA-1 P107 PEPTIDE, COLLAGEN, AND KERATIN - IMPLICATIONS FOR THE PATHOGENESIS OF RHEUMATOID-ARTHRITIS [J].
BIRKENFELD, P ;
HARATZ, N ;
KLEIN, G ;
SULITZEANU, D .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 54 (01) :14-25
[7]   Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma [J].
Blank, Christian U. ;
Rozeman, Elisa A. ;
Fanchi, Lorenzo F. ;
Sikorska, Karolina ;
van de Wiel, Bart ;
Kvistborg, Pia ;
Krijgsman, Oscar ;
van den Braber, Marlous ;
Philips, Daisy ;
Broeks, Annegien ;
van Thienen, Johannes, V ;
Mallo, Henk A. ;
Adriaansz, Sandra ;
ter Meulens, Sylvia ;
Pronk, Loes M. ;
Grijpink-Ongering, Lindsay G. ;
Bruining, Annemarie ;
Gittelman, Rachel M. ;
Warren, Sarah ;
van Tinteren, Harm ;
Peeper, Daniel S. ;
Haanen, John B. A. G. ;
van Akkooi, Alexander C. J. ;
Schumacher, Ton N. .
NATURE MEDICINE, 2018, 24 (11) :1655-+
[8]   The biology and role of CD44 in cancer progression: therapeutic implications [J].
Chen, Chen ;
Zhao, Shujie ;
Karnad, Anand ;
Freeman, James W. .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
[9]   Topical delivery of siRNA into skin using SPACE-peptide carriers [J].
Chen, Ming ;
Zakrewsky, Michael ;
Gupta, Vivek ;
Anselmo, Aaron C. ;
Slee, Deborah H. ;
Muraski, John A. ;
Mitragotri, Samir .
JOURNAL OF CONTROLLED RELEASE, 2014, 179 :33-41
[10]   Current and future technological advances in transdermal gene delivery [J].
Chen, Xianfeng .
ADVANCED DRUG DELIVERY REVIEWS, 2018, 127 :85-105